• Company’s quick and clean method of extracting magnesium, lithium and other valuable industrial minerals from well brine, while purifying byproduct mining wastewater, provides huge operational advantage
• MGXMF owns proprietary nanoflotation technology that, in just days versus months, can extract valuable minerals, such as magnesium and lithium, from oilfield lithium brine while purifying the wastewater byproduct
• MGX controls significant interest in magnesium, lithium and silicon assets throughout North America; it is Canada’s largest holder of lithium brine assets with around two million acres in North America
• MGX and its engineering partner use exclusively licensed and patented nanoflotation technology to offer oilfield operators wastewater handling solutions; this proprietary technology separates heavy metals and hydrocarbons from brine
• Company’s joint venture partner, Power Metals Corp., recently announced initial assay results from its drilling of 26.0 meters at Case Lake property located near Cochrane, Ontario

MGX Minerals, Inc.’s (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) proprietary and patented nanoflotation technology that quickly and cleanly extracts valuable industrial minerals, such as magnesium and lithium, from oilfield brine and purifies byproduct wastewater is a boon to investors. Its process is faster and less costly than other methods, and it is also far more environmentally friendly.

MGX is focused on creating shareholder value through development of its large-scale and diverse industrial mineral portfolios. The Vancouver, British Columbia-based company is disrupting the mining industry by quickly processing brine generated by oil and gas wells and extracting valuable minerals, such as magnesium and lithium carbonate — a key ingredient in the manufacture of lithium-ion batteries.

MGX has diverse mining holdings throughout Alberta and British Columbia, Canada, as well as in Utah. According to Reuters, it has acquired acreage that makes it one of Canada’s largest holders of lithium brine assets, with around two million acres in North America (http://dtn.fm/fd4HU). As announced by MGX, its joint venture partner, Power Metals Corp., recently received initial assay results from its drilling at the Case Lake property located near Cochrane, Ontario (http://dtn.fm/x9Hah).

Key to its valuation, MGX is able to perform the extraction and purification process much faster and more cost-effectively through its proprietary nanoflotation technology. This process separates heavy metals and hydrocarbons from brine, purifying the byproduct wastewater and creating brine feedstock for MGX’s quick recovery process. It has integrated the technologies of PurLucid Treatment Solutions, Inc., and its own.

Adding credibility to the story, PurLucid recently received $8.2 million in government funding (http://dtn.fm/p5KRU) from Sustainable Development Technology Canada (“SDTC”) and Emissions Reduction Alberta. Utilizing MGX resources, PurLucid will implement the lithium recovery process as a separate but associated project as early as January 2018. Extending from success achieved with the PurLucid pilot petrolithium recovery system deployed in August 2017, fabrication of the first small commercial PurLucid lithium recovery system will be completed in December 2017 and be ready for use in 2018 on the treated brines from the grant-supported project and other MGX brines successfully trialed with the bench-scale and pilot systems.

Jared Lazerson, MGX CEO, told Greentech Media (http://dtn.fm/C402l), “We’re currently in talks with many oil and gas companies for use of their water as well as (having) our own operations in Utah.” Lazerson said it is possible to get minerals from oil-extraction in just a few days rather than the 18 months that it normally takes under other methods. Not only is MGX’s process faster, it is also less costly.

Lazerson added that the MGX process has a pilot plant that can process a cubic meter of liquid per hour – allowing for a recovery rate of 99% for magnesium and almost 70% for lithium – and the byproduct is purified as clean water. MGX is already processing wastewater from two mines and six oil and gas sites across North America, according to Mines&Technology’s online site MINING.com (http://dtn.fm/5DzmM).

In a company press release (http://dtn.fm/8B67x), Lazerson said, “Removal of very high levels of magnesium opens up a large number of global lithium brine sources for consideration that were previously considered too high in magnesium. This represents a triumph of technology over perceived resource quality, in particular, that the magnesium has been extracted in a common form of widely used industrial mineral compound.”

According to researcher Future Market Insights (http://dtn.fm/qMM5o), the market for magnesium is projected to grow to $6.2 billion in revenues by 2026, reflecting a compound annual growth rate (CAGR) of 7.3%.

The global lithium market is projected by the Freedonia® Group to reach $1.7 billion with a 8.9% CAGR through 2019 (hhttp://dtn.fm/BURt2). Even larger is the market for lithium-ion batteries, which is expected to hit $46.21 billion by 2022, growing by a CAGR of 10.8%, as analyzed by Allied Market Research (http://dtn.fm/xpSd5). Electric and hybrid cars, smart phones and other devices will propel that growth.

For more information, visit the company’s website at www.MGXMinerals.com

Let us hear your thoughts: MGX Minerals Inc. Message Board

• Pioneered comprehensive card processing payment operation dedicated to medical marijuana industry
• Proprietary merchant processing system serves demands of the legal $6 billion cannabis market
• Alternative payment solution empowers businesses by tracking sales and tax collection, frees consumers and retailers from solely using cash
• Fully compliant with FinCEN’s anti-money laundering efforts

Medical Cannabis Payment Solutions (OTC: REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

For more information, visit the company’s website at www.MedicalCannabisPaymentSolutions.com

Let us hear your thoughts: Medical Cannabis Payment Solutions Message Board

• Penetrating key markets in China efficiently with paid platforms generating multiple revenue streams seen as key to its success
• Joint venture with fine wine marketer and distributor Shewn International Group, based in Shanghai, seen as beginning of low-cost and quick way to gain market share, Crystal Equity Research report finds
• Crystal Equity projects that the company will do $2.3 million in FY2018

Moxian, Inc. (NASDAQ: MOXC) has adopted two new dual strategies for growth: penetrating the online-to-offline (O2O) market by entering joint ventures and selling $2 million-$4 million retail businesses. The efforts to reach customers in key China markets quickly and at low cost can drive its success, Crystal Equity Research indicated in an August 2017 report (http://dtn.fm/5oZJz).

Moxian is a Shenzhen, China-based company that is executing its strategy of converting its two platforms — Moxian+ Business and Moxian+ User apps — in the O2O market from unpaid to paid (http://dtn.fm/n6qpX). This would launch numerous revenue streams:  transaction fees of 1% of all processing by UnionPay on these apps, subscription revenue, mobile advertising income, licensing fees, plus OEM fees. Moxian is an integrated platform operator and an early-stage company.

One of the changes the company has made to its overall strategy is to target larger retail businesses, those doing $2 million to $4 million in annual sales, rather than the small and medium sized enterprises (SMEs) it focused on prior.

Key to MOXC’s unique attractiveness is its built-in UnionPay digital money collection process app — a highly desired feature by merchants (http://dtn.fm/IG9aU). That processing also provides a revenue stream to MOXC on every transaction. UnionPay is the dominant player in China’s digital payments system, the Crystal Equity Research report indicated, and it owns 25% of the global market for credit cards with a presence in 160 countries worldwide, including the U.S.

The report adds that the Shewn International Groups’ Memorandum of Understanding (MOU) signed by Moxian is critical in assessing its future performance and gaining investor confidence.  “We view it as an important catalyst for valuation,” the Crystal report concluded. Shewn International Group is a distributor of fine wines. It has plans within China to market its wines in luxury apartments and other high end locations via self-pay elaborate vending machines, which keep the wines at precise temperatures. It hopes to install some 500,000 of the machines throughout the country, the report said. Under the agreement, the two companies would share technology and market strengths.

For more information, visit the company’s website at www.Moxian.com

• Mineral known as ‘the new gasoline’ attractive to auto industry
• 92 Resources developing sites in Canada’s northwest, Quebec

The increasing drive among the world’s industrialized nations to find more environmentally friendly fuel sources is a boon to junior mining companies such as 92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) (http://dtn.fm/PRGj6), which are poised to help supply the global need for tech-friendly lithium.

Lithium has become an in-demand resource for the auto industry as manufacturers try to anticipate the consequences of recent political decisions favoring electric vehicles over their dominant gas-powered cousins (http://dtn.fm/z1zsD). In July, France and Britain joined the number of nations who have declared their intentions of prohibiting the sale of vehicles driven by fossil fuels, working against an established deadline to promote alternative means of transportation.

Electric vehicles powered by lithium and cobalt batteries have proven particularly attractive to markets within metropolitan areas, where gasoline’s advantages involving longer travel distances and established refueling networks are less critical. And automakers have taken notice, with many of them now committed to release a lineup of all-electric vehicles or hybrids with electrical plug-in capabilities during the coming years.

Lithium has also applications in technology that has become ubiquitous within the world’s societies during the past two decades, particularly mobile phones, tablets and laptops.

Independent energy producers have also begun to integrate industrial-sized battery systems into the power infrastructure.

Goldman Sachs referred to lithium as “the new gasoline,” but currently the surging demand is being met with an inadequate market supply, creating a lag-time in development and a rising trend in prices. During 2015, China’s import costs for 99 percent pure lithium carbonate doubled.

International mining and minerals researcher Roskill has estimated that in just over eight years, a potential shortfall of 26,000 metric tons could occur as industries call for more than 785,000 metric tons per year of lithium carbonate (http://dtn.fm/6RwCy).

92 Resources aims to capitalize on governments’ and industry leaders’ taste for lithium. The company has hard rock lithium extraction projects in Canada’s Northwest Territories as well as in Quebec.

A government grant enabled the company to begin work during the summer on the Northwest Territories Hidden Lake site, where scoping test work accomplished an overall extraction of 97 percent in lithium-bearing pegmatites (http://dtn.fm/Hr7LK).

“The Project has now been significantly de-risked through the high quality, low-iron spodumene confirmed to be present at Hidden Lake, as well as the high lithium extractions that may be expected using standard methods,” 92 Resources president and CEO Adrian Lamoureux stated in a related press release. The Quebec exploration includes 115 mineral claims of more than 114,000 acres with known large-crystal pegmatites outcroppings.

“As we continue to aggressively advance our flagship Hidden Lake Lithium Project, we feel it is critical to maintain a pipeline of additional high-quality, early-staged, lithium pegmatite projects, each with potential as stand-alone opportunities,” Lamoureux stated.

For more information, visit the company’s website at www.92Resources.com

Let us hear your thoughts: 92 Resources Corp. Message Board

• Investor Relations operations revenues jumped 186% in 1Q2018, driven by expanded program offerings, such as CIIX’s multi-media and presentations in roadshows customized to help clients build their brands
• CIIX also receives new revenue from consumer product sales of its hemp-based line generated by a company subsidiary formed in early 2017
• Company had 76% YOY boost in operating sales in fiscal 2017; sets FY2018 goal of greater than 100% increase in sales, lower costs, and profitability

ChineseInvestors.com, Inc. (OTCQB: CIIX) is driving revenue growth from its Investor Relations Division, realizing a 186% jump in sales for 1QFY2018. The first quarter revenue in FY2018 in this segment was $258,366 compared to sales of $90,312 in the first quarter of FY2017. To generate growth in FY2018, CIIX developed new products, such as multi-media and road show presentations for both brand- and company reputation- building, its 10K SEC filing reports (http://dtn.fm/EBZv1). In FY 2017, sales of Investor Relations had been second to those of Subscriptions.

That October 2017 10K filing also showed that Investor Relations was the single largest generator of corporate three-month revenues, contributing 62% of CIIX’s total sales. CIIX also detailed its new revenue stream from its subsidiary’s revenues from consumer product sales of hemp -based products.

CIIX has set the table for its FY2018 goals: YOY sales increases of more than 100%, profit and reduced costs. Warren Wang, CIIX CEO, has expanded the company’s board by three persons with vast business experience and also re-installed Paul Dickman as CFO. He originally served in that position from July 2010 through October 2016.

By strengthening the business and management bench at CIIX, Wang is committed to growing the diversified company to reach its ultimate goal: becoming the primary medical cannabis publicly-traded company serving the global Chinese speaking community.

To that end, CIIX offers this community a variety of services. This includes a retail store based in China for its hemp-oil based cannabidiol (CBD) products, a subsidiary that sells its hemp-infused skin care products plus an offering of a wide range of educational, consulting and media services. CIIX produces a daily newscast on cryptocurrency emanating from the NYSE in a video broadcast titled, “Bitcoin Multimillionaire,” in partnership with Wall Street Multimedia, Inc. (WSM).

For more information, visit the company’s website at www.ChineseInvestors.com.

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

• Trusted resource for high-quality, cost-effective NIJ-certified body armor
• Serving U.S. government and law enforcement agencies for over 20 years
• Supplied ordnance to U.S. forces in Iraq and Afghanistan

Since 1997, HighCom Global Security, Inc. (OTC: HCGS) has been supplying the U.S. government and law enforcement agencies throughout the nation with a variety of soft and hard body protecting solutions. When U.S. troops were deployed in Iraq and Afghanistan, the company was there, playing a major role supplying hundreds of thousands of hard armor pieces. As a result, HighCom is now recognized as a trusted and valuable resource for high quality and cost-effective NIJ-certified armor solutions. Located in Columbus, Ohio, the company’s manufacturing and distribution facility and its R&D and ballistic laboratory allows it to effectively manage all critical aspects of design, production and supply of its products. And HighCom continues to work with the largest manufacturers and distributors in the world through its OEM and private-label program, many of whom rely on HighCom to design, develop, test and manufacture armor solutions under subcontract agreements.

Protecting law enforcement officers (LEOs) with effective body armor has become ever more crucial in recent times. Data published by the National Law Enforcement Officers Memorial Fund (NLEOMF) indicate the rising level of threat to LEOs. In 2016, law enforcement fatalities nationwide rose to their highest level in five years, with 135 officers killed in the line of duty (http://dtn.fm/72Tsn). This represents a 10 percent increase over the 123 who died in the line of duty in 2015 and is the highest total since 2011, when 177 officers made the ultimate sacrifice. Firearms-related incidents were the number one cause of death in 2016, with 64 officers shot and killed across the country. This represents a significant spike—56 percent—over the 41 officers killed by gunfire in 2015. Of the 64 shooting deaths of officers in 2016, 21 (33%) were the result of ambush-style attacks—the highest total in more than two decades. If nothing else, these alarming statistics demonstrate the pressing need LEOs have for effective body armor.

And HighCom, in the business of saving lives, has a wide range of body protection gear. Its product lineup includes Type IIA body armor, which offers basic protection against smaller caliber handgun threats; Type II body armor, which provides protection against larger handguns, including many common smaller caliber pistols with standard pressure ammunition and against many revolvers; Type IIIA body armor, which can resist heavy pistol calibers including most law enforcement ammunition and many higher powered revolvers, and Type III and IV body armor, which provide protection against rifle rounds, generally only used in tactical situations.

In February 2017, the company introduced four new hard armor models to its ballistic product line, receiving NIJ compliance status through the National Institute of Justice Compliance Testing Program (NIJ CTP), the only nationally accepted standard for body armor. And in July 2017, approval was received from the NIJ on two additional armor models: a Level IIIa elite, lightweight, high-performance soft armor panel; and a Level III++, multi-curve, hard armor ballistic plate. With the launch of these new models, HighCom Armor now has 11 hard armor NIJ 0101.06 certified ballistic plate models, as well as five soft armor NIJ 0101.06 certified panel solutions.

Operating from a 32,865 square foot manufacturing and distribution facility located in Columbus, Ohio, HighCom can handle large scale, time-sensitive global supply needs. Its logistics center in Florida serves customers in North America, such as the Department of Defense and the Department of Homeland Security, local law enforcement agencies, correctional facilities, municipal authorities and large corporations, as well as others throughout the world. Past sales have been to Asia, Africa, Europe, Latin America, and the Middle East. Recent financial performance has exceeded expectations. Revenues for the second quarter 2017 were $1.5 million, a triple-digit increase over revenues of $698K reported in the second quarter of 2016. For the first six months of 2017, HighCom Global reported revenues of $2.6 million, an increase of more than $700,000 from revenues of $1.9 million reported in the first half of 2016.

For more information about the company, visit its website at www.HighComGlobal.com

Let us hear your thoughts: HighCom Global Security, Inc. Message Board

• Skinvisible Pharmaceuticals, Inc. is making confident steps toward the large-scale distribution of its hand sanitizer in China
• Clinical studies show that frequent hand sanitization is the only effective non-pharmaceutical measure for influenza prevention
• Worries about the spread of avian influenza and its high mortality rate have triggered the introduction of more rigorous prophylactic measures and market growth

H7N9 (a type of avian influenza virus) could be the one to cause the next global flu pandemic, the World Health Organization (WHO) warns (http://dtn.fm/Nby8B). Luckily, the flu prophylactic market is already offering some adequate options, and DermSafe® by Skinvisible, Inc. (OTCQB: SKVI) subsidiary Skinvisible Pharmaceuticals, Inc. is one of them. In June, Skinvisible announced the first international sale of DermSafe in China – a country that’s known to have the first reported cases of human avian influenza infections.

As winter approaches, researchers warn that the risk of flu viruses spreading increases. H7N9 infections have been sporadic so far, but the virus has been mutating (http://dtn.fm/KqE8y). This would be its sixth year of existence, and, over this period of time, avian influenza has had a mortality rate of 36 percent among 1,562 lab-confirmed infections. The fifth wave of the viral infection (starting in 2017) has been the deadliest one yet. Out of 764 infected individuals, 250 died because of the virus.

Virus mutations, more serious epidemics and their consequences are making researchers work hard on the creation of flu prevention products. Influenza vaccines are becoming more popular than ever before, with a projected growth in the U.S. from 147.8 million doses in 2016 to 179 million doses in 2017 (http://dtn.fm/9pFYj). The current value of the market is estimated at $4 billion.

Apart from vaccination, the use of the right personal hygiene products is another highly effective way to prevent the spread of flu viruses, including H7N9. According to a report presented in the BMC Public Health Journal, frequent hand washing and sanitization (at least five times per day) is the only non-pharmaceutical prophylactic measure that is a statistically-significant protective factor in the case of pediatric influenza (http://dtn.fm/h6J06).

Hand sanitizers like Skinvisible’s DermSafe could be one of the answers when it comes to influenza prevention. Independent studies of the product suggest that DermSafe kills germs immediately upon application, and it also provides four additional hours of protection upon topical use. In addition to its powerful anti-bacterial/viral properties, DermSafe is free from alcohol. This means that it doesn’t have a drying effect, and it feels pleasant on the skin.

DermSafe’s formulation features chlorhexidine gluconate in a four-percent concentration. This ingredient has proven its ability to kill both gram-positive and gram-negative bacteria, as well as viruses. It also offers long-lasting protection from germs when human skin comes in contact with hard surfaces. Through clinical tests, it’s been proven that the active ingredient in DermSafe is effective against H7N9, as well as H1N1 – the swine flu virus.

Since DermSafe is approved for sale by Health Canada, prior to its product launch in China, DermSafe was used by the Canadian Olympic team during the games in Rio. The Olympic team was capable of successfully addressing concerns stemming from water quality through the use of the hand sanitizer. The Canadian Olympic team will also be protected by DermSafe in February 2018 at the Winter Olympic Games in South Korea.

Skinvisible Pharmaceuticals is looking for opportunities to expand the distribution of DermSafe globally. In 2013, the Company obtained registration rights for DermSafe in Belgium. Through this designation, the hand sanitizer can be registered and distributed in most EU countries. The larger long-term strategy includes the effective distribution of the company’s product globally.

For more information, visit the company’s website at www.Skinvisible.com

Let us hear your thoughts: Skinvisible, Inc. Message Board

• World demand for lithium expected to increase 300% by 2025
• Global lithium compounds market projected to reach U.S. $5.87 billion by 2020
• Electric vehicles are on track to take 54% of new car sales by 2040
• Exploration of Bristol Lake Project reveals excellent lithium-bearing brine harvest potential

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF), a Canadian energy exploration and development company, is aggressively working to fill the increasing demand for lithium as it focuses on its Bristol Dry lake lithium brine project located in California’s Mojave Desert. As a junior mining company, Standard Lithium is building one of the largest portfolios of high quality, domestic U.S. lithium brine assets.

Bloomberg New Finance reports the global long-term outlook for electric vehicles is moving faster than the firm predicted a year ago. EVs are on track to accelerate to 54 percent of new car sales by 2040 as more countries around the world seek alternatives to the internal combustion engine and the resulting pollution they cause (http://dtn.fm/bWCd7). In fact, the dynamics at play for lithium growth run the gamut as the future of transportation and energy efficiency accelerate the need for more of the world’s lightest metal.

Standard Lithium’s geophysics team recently concluded a comprehensive gravity survey over the company’s entire Bristol Dry Lake Lithium Project containing 35,000 acres of placer mineral claims and private property. Initial interpretation of the data indicate that high concentrations of lithium-bearing brines are present throughout the company’s mineral lease agreement claims (http://dtn.fm/EoFK0).

Key to the project’s success is the area’s excellent mining infrastructure that tackles the primary challenges facing lithium mining – access and cost-effective production. Through a strategic partnership with two permitted brine operators, National Chloride Corporation of America (NCAA) & TETRA Technologies (TETRA) , Standard Lithium has immediate access to conduct exploration brine sampling, evaporation and lithium processing activities, enabling a fast-track project development schedule.

In addition to the Bristol Lake Brine Project, Standard Lithium has signed a Letter of Intent with a NYSE-listed chemical processing company for 30,000-plus acres of brine leases in the Smackover Formation within southern Arkansas. This brine resource may be one of the lithium industry’s most promising projects to develop (http://dtn.fm/KY3Un), STLHF management believes. As world demand for lithium continues to grow, so does Standard Lithium’s determination to be a major player in the lithium compounds market.

For more information about the company, visit http://nnw.fm/standardlithium

• Clinical-grade salve is designed for topical skin use and contains full spectrum hemp oil, menthol, and essential oils; it is developed to treat minor skin irritations and tight or sore muscles
• Eqova will distribute salve to patients through licensed health practitioners
• Marijuana Business Conference (MJBizCon) is the industry’s premier and largest trade show, generating for Eqova an audience of potentially thousands of cannabis-related executives

Grey Cloak Tech, Inc. (OTCQB: GRCK), through subsidiary Eqova Life Sciences, will introduce CannaBio Salve at the Marijuana Business Conference (MJBizCon), to be held November 14-17 in Las Vegas (http://dtn.fm/3NbQb). Per the announcement, it is the industry’s premier cannabis trade show. CannaBio Salve is a topical skin product containing full spectrum hemp oil, menthol and essential oils.

The salve is designed to treat minor skin irritations and tight or sore muscles. It is Eqova’s second product developed for topical skin use.

GRCK acquired 100% of Eqova in an all-stock transaction last month. Eqova offers clinical-grade products manufactured in cGMP-compliant labs located in the United States. It is focused on the medical practitioner market, offering products that are carefully researched and tested by third-parties before and after marketing. These products use full-spectrum hemp oil plus other ingredients to achieve standardized dosing. Distribution to patients is achieved through licensed health practitioners, as noted on Eqova’s website.

In today’s news release, Matthew Grabau, Eqova Life Sciences co-founder and CMO, said, “We’re very excited about introducing CannaBio Salve. There has been a lot of interest from our practitioners in the product already. We’ve been taking pre-sales for the product for quite some time, and we fully expect it to be one of top two sellers.”

Eqova’s management team will be at MJBizCon in Las Vegas to introduce CannaBio Salve, as well as the rest of the company’s line. At this trade show, Eqova’s products will be seen by potentially thousands of cannabis-related executives.

For more information, visit the company’s website at www.GreyCloakTech.com

Let us hear your thoughts: Grey Cloak Tech, Inc. Message Board

• High-margin licensing royalties of 5-10% of gross sales of its patented bioscience technology and process are an attractive valuation builder; LXRP sees more licensing opportunities in 2018
• LXRP’s technology is patented in the U.S. and Australia; company has national/regional filings pending in 44 countries

Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) generates revenue by out-licensing its patented global technology related to ingestion of edible cannabinoids at a rate of 5-10% of gross sales to its third-party partners. LXRP has also expanded its process of improved and faster inhalation by the body of fat-soluble vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) in pain medications, and even nicotine, a good example of bioabsorption breakthrough technology (http://dtn.fm/ssLY4). LXRP is now positioned to license its technology to tobacco giants and major drug companies, as well as cannabinoid biopharmaceutical companies.

As a result, LXRP sees new business opportunities in 2018. The company is now positioned to out-license — at a high royalty rate — its intellectual property (IP) to biopharmaceutical companies as a partner rather than a competitor, working with other companies, including cannabinoid edible producers, instead of competing with them.

An R&D-driven company, LXRP is disrupting the global industry by specializing in the ingestion of edible forms of cannabinoids. Its technology and process platform offers more rapid forms of delivery and intestinal absorption of orally-taken cannabinoids, vitamins, nicotine and non-steroidal inflammatory drugs. Its patented process not only improves the body’s absorption of edible cannabinoids; it also masks taste, reduces by roughly 75% the time of onset, and increases bio-absorption by 5-10x. The company has secured patents related to its processing technology in the U.S. and Australia, and it has a portfolio of some 19 national/regional patent application filings in some 44 countries (http://dtn.fm/Y6ekx).

Primarily a B2B company, LXRP also makes for demonstration purposes branded consumer products under the ViPova™, Lexaria Energy Foods, and TurboCBD™ brands. It recently acquired the remaining 49% of its majority owned Poviva Tea LLC subsidiary (http://dtn.fm/G3vKs). It now owns 100% ownership interest, reaffirming its commitment to the ViPova product lines, as noted by the company in a recent news release.

Separately, in financial news, LXRP has extended the date of its warrants issued on January 19, 2017, to expire on January 19, 2019. The exercise price and the quantity of the warrants has not changed, it said in a 8K SEC filing. LXRP, in its corporate presentation, said that the next round of capital investment is expected to be in “plant to bloodstream” companies, such as itself.

For more information, visit the company’s website at www.LexariaBioscience.com

Let us hear your thoughts: Lexaria Bioscience Corp. Message Board